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In  previous communications from this  laboratory  (1-3)  and  others  (4)  a 
distinction has been made between infectious  hepatitis and homologous serum 
jaundice.  Certain  similarities  and  differences between  these two conditions 
have been defined on the basis of clinical and epidemiologic data  as well as 
from experiments in the transmission of virus to human volunteers (1-4).  The 
exact relationship between these two conditions is not clearly understood.  It 
is not yet known whether  the apparent differences noted between them are 
representative of actually ~ifferent viruses or of antigenic differences of various 
strains of a single ,drus. 
The  immunologic relationships  between  homologous  serum  jaundice  and 
infectious hepatitis are also not clear.  Both conditions probably belong to the 
same  general  group  but  the  evidence for cross-immunity between  them  is 
contradictory.  Oliphant (5) showed apparent protection in human volunteers 
convalescent from serum jaundice when reinoculated with a strain of infectious 
hepatitis.  In  contrast  are reports from this  laboratory  (6)  and  by Neefe, 
Stokes, and Gellis (4) stating that patients convalescent from experimentally 
produced homologous serum jaundice are susceptible when reinoculated with 
two different strains of infectious hepatitis.  Moreover, it has been observed 
that troops, convalescent from homologous serum  jaundice induced  by  the 
inoculation  of human blood products,  contracted  infectious  hepatitis  while 
occupying a  zone where this disease was endemic  (7,  8).  Conversely, it has 
been reported that patients who have had infectious hepatitis are susceptible to 
homologous serum jaundice when inoculated with human blood products ac- 
cidentally contaminated  with  the causative agent of this condition (9, 10). 
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Homologous immunity has  been  shown to  be present  in  both  conditions. 
Planned experiments  on human volunteers have demonstrated that  subjects 
convalescent from both serum jaundice  (4, 5)  and infectious hepatitis  (4)  are 
apparently immune when reinoculated several months later with an homologous 
strain.  Neefe, Stokes, and Gellis  (4) have recently summarized the epidemio- 
logical data which suggest that one attack of infectious hepatitis is followed by 
some  degree  of immunity.  Moreover,  the  demonstration  of  the  protective 
effect of normal human gamma globulin when administered during the short 
incubation period of epidemic infectious hepatitis  also suggests the presence 
of certain neutralizing substances in the blood of the normal adult population, 
possibly as a  result  of a  previous clinical or subclinical attack of the disease 
(11-13).  Attempts to demonstrate a similar protective effect of normal human 
gamma globulin when administered during the long incubation period of homol- 
ogous serum jaundice have shown conflicting results (14, 15).  In one study a 
significant prophylactic effect was observed when two injections of  10 cc.  of 
gamma globulin were given a month apart, while in two other studies no benefit 
was found when a  single injection of 10 cc. was given.  The reasons for this 
discrepancy are not clear but it is possible that size of dose of gamma globulin, 
the long period of viremia in homologous serum jaundice,  and the  fact that 
viremia  may be  already  established  prior  to  the  administration  of  gamma 
globulin may be important factors. 
During the past two years in the course of experiments in the transmission of 
infectious hepatitis to human volunteers conducted by the U. S. Army Neuro- 
tropic Virus Commission, it has been possible to test the immunity of some of 
the convalescent subjects.  It is the purpose of this paper to describe this work 
and to report  the presence  of homologous immunity in  9 human volunteers 
convalescent from infectious hepatitis, when reinoculated with the same strain 
of virus after a lapse of some months. 
Materials and  Methods 
Subjects.--21 human volunteers, ranging in age from 19 to 29 years were employed,  9 
of these men were convalescent 6 to 9 months from infectious hepatitis  experimentally in- 
duced in this laboratory by the oral or parenteral administration of infectious feces or serum. 
Their incubation periods had ranged from 16 to 30 days and all 9 had been jaundiced, with 
courses of disease ranging from mild to very severe.  The remaining 12  men had no pre- 
vious history of infectious hepatitis and served as controls.  Prior to the onset of disease 
these volunteers were housed in institutions in Middletown, Norwich, and  New Haven, 
Connecticut.  Each man was seen at least once a week and the period of observation ex- 
tended for 3 to 4 months.  Volunteers  who became sick were hospitalized in the  Isolation 
Pavilion of  the  New Haven Hospital. 
Laboratory Observatlons.--The following tests of liver function were performed at weekly 
intervals throughout the period of observation: (1) quantitative serum bilirubin;  1 (2) brom° 
1  According to the method of Malloy and Evelyn (16) using the photoelectric colorimeter. W.  PAUL  HAVENS~  JR.  405 
sulfalein dye retention test  s  (17); (3)  cephalin-cholesterol flocculation (Hanger)  (18); (4) 
thymol turbidity test (19); (5) determination of bilirubin (20) and urobilinogen (21) in the 
urine. 
Virus.--The  strain of infectious hepatitis  virus  used in this laboratory  was originally 
obtained from the stool of a U.  S. Army soldier (BE) who contracted  epidonic infectious 
hepatitis in Sicily in 1943 (22).  It has been through four passages in human volunteers to 
date.  This agent is filtrable through an L2 Chamberland filter and withstands  heating to 
56°C. for 30 minutes (23).  It has produced the disease in 27 out of 40 human volunteers 
(including those reported here) following  parenteral or oral inoculation with incubation  periods 
ranging from 15 to 34 days. 
The inoculum employed in this experiment was serum representing  the 2nd, 3rd,  and 
4th human passage of virus.  The serum was obtained during the first 5 days of infectious 
hepatitis experimentally induced in human volunteers by feeding or parenteral  inoculation of 
our strain of virus.  This serum had been stored at dry-ice box temperature for periods ranging 
from 5 to 14 months.  Before  using, it was thawed at room temperature and heated to 56°C. 
TABLE I 
Results of Administration of Icterogenic Serum (Infectious Hepatits) to Normal Human Volun- 
teers and to Human  Volunteers  Convalescent from Experimentally Induced Infectious Hepatitis 
Subjects 
(A) Convalescent 6-9 mos  ................. 
(B)  Normal controls ..................... 
(C)  Convalescent 6 mos  ................... 
(D)  Normal controls ...................... 
Route 
Oral 
Oral 
Par.* 
Par. 
No.  of  volunteers 
i  In¢cuIated  H¢~al  fis  __ 
3  3 
4  0 
Incubation 
period 
days 
24-26 
21-30 
* Par. --- parenteral 
for 30 minutes to destroy bacteria.  Serum in amount ol 0.5 cc. was administered to the 9 
convalescents by the same route (parenterally  or orally)  by which they had received  the 
inoculum which produced their  initial  disease. The healthy controls  were inoculated with 
the same serum in amounts ranging from 0.01 to  0.5 cc.  A period of 1 to  3 months elapsed 
between the inoculation of the various groups of controls  and convalescents.  During this 
time the infectious  serum was kept frozen at dry-ice  box temperature. 
RESULTS 
All 9 men convalescent from infectious hepatitis resisted reinoculation with 
infectious material which induced infectious hepatitis in 8 out of 12 previously 
healthy  control  human  volunteers  (Table  I).  The  convalescent  subjects 
remained asymptomatic throughout the period of observation and their various 
tests of liver function were all within normal limits with the exception of 4 men 
who  developed  positive  cephalin-cholesterol flocculation for  several  weeks 
during the period of observation.  It is difficult to interpret the significance of 
210 per cent retention in the blood 30 minutes after  the intravenous injection of 5 rag. 
bromsulfalein/kg, of body weight was considered the maximum normal level. 406  IMMUNITY IN  INFECTIOUS HEPATITIS 
these positive cephalin-cholesterol flocculations.  They may represen  t evidence 
of minimal disturbance  of hepatocellular function.  Similar border line dis- 
turbance of function was reported by Neefe, Stokes, and Gellis (4) in testing for 
immunity in patients convalescent from homologous serum jaundice: 
SUMMARY AND CONCLUSIONS 
1.  9 human volunteers, convalescent from infectious hepatitis experimentally 
induced'by a strain of virus employed in this laboratory, were resistant when 
reinoculated with the same strain of virus, 6 to 9 months later. 
2.  8 out of 12 previously healthy control subjects developed infectious hepa- 
titis with jaundice following administration of this same material. 
3.  The demonstration of homologous immunity produced by this strain of 
virus is in agreement with the demonstration by others of homologous immunity 
produced by another strain of infectious hepatitis virus. 
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